Michael Petusky

Stock Analyst at Barrington Research

(1.98)
# 3,016
Out of 4,944 analysts
210
Total ratings
35.68%
Success rate
-8.46%
Average return

Stocks Rated by Michael Petusky

Surmodics
Aug 11, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $38.09
Upside: -
DENTSPLY SIRONA
Aug 8, 2025
Maintains: Outperform
Price Target: $21$18
Current: $13.79
Upside: +30.53%
U.S. Physical Therapy
Aug 8, 2025
Maintains: Outperform
Price Target: $98$103
Current: $87.30
Upside: +17.99%
Haemonetics
Aug 8, 2025
Maintains: Outperform
Price Target: $95$86
Current: $52.86
Upside: +62.69%
LeMaitre Vascular
Aug 6, 2025
Upgrades: Outperform
Price Target: $95
Current: $95.28
Upside: -0.29%
Henry Schein
Aug 6, 2025
Maintains: Outperform
Price Target: $86$78
Current: $68.40
Upside: +14.04%
Merit Medical Systems
Jul 31, 2025
Maintains: Outperform
Price Target: $103
Current: $85.25
Upside: +20.82%
Anika Therapeutics
Jul 31, 2025
Maintains: Outperform
Price Target: $19$15
Current: $8.95
Upside: +67.60%
Option Care Health
Jul 10, 2025
Maintains: Outperform
Price Target: $38
Current: $28.45
Upside: +33.57%
Orthofix Medical
Jun 23, 2025
Initiates: Outperform
Price Target: $16
Current: $13.99
Upside: +14.37%
Downgrades: Market Perform
Price Target: n/a
Current: $2.37
Upside: -
Maintains: Outperform
Price Target: $2.25
Current: $1.34
Upside: +67.91%
Maintains: Outperform
Price Target: $1.5$1.25
Current: $0.94
Upside: +32.98%
Downgrades: Market Perform
Price Target: n/a
Current: $7.60
Upside: -